share_log

Shandong Fengyuan Chemical Co., Ltd.'s (SZSE:002805) 16% Gain Last Week Benefited Both Retail Investors Who Own 56% as Well as Insiders

Shandong Fengyuan Chemical Co., Ltd.'s (SZSE:002805) 16% Gain Last Week Benefited Both Retail Investors Who Own 56% as Well as Insiders

山東豐元化工股份有限公司(SZSE:002805)上週上漲了16%,受益於持有56%股份的零售投資者和內部人員。
Simply Wall St ·  09/05 20:18

Key Insights

關鍵見解

  • Shandong Fengyuan Chemical's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 25 shareholders own 44% of the company
  • Insider ownership in Shandong Fengyuan Chemical is 31%
  • 山東豐源化工擁有大量散戶投資者的所有權,這表明關鍵決策受廣大公衆股東的影響
  • 前25名股東擁有公司44%的股份
  • 山東豐源化工的內部所有權爲31%

Every investor in Shandong Fengyuan Chemical Co., Ltd. (SZSE:002805) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 56% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

山東豐源化工有限公司(SZSE:002805)的每位投資者都應了解最強大的股東群體。我們可以看到,散戶投資者擁有該公司的大部分股份,所有權爲56%。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

While retail investors were the group that benefitted the most from last week's CN¥462m market cap gain, insiders too had a 31% share in those profits.

儘管散戶投資者是從上週46200萬元人民幣的市值增長中受益最大的群體,但內部人士在這些利潤中也佔有31%的份額。

Let's delve deeper into each type of owner of Shandong Fengyuan Chemical, beginning with the chart below.

讓我們從下圖開始,深入研究山東豐源化工的每種所有者。

big
SZSE:002805 Ownership Breakdown September 6th 2024
SZSE: 002805 所有權明細 2024 年 9 月 6 日

What Does The Institutional Ownership Tell Us About Shandong Fengyuan Chemical?

關於山東豐源化工,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

Shandong Fengyuan Chemical already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shandong Fengyuan Chemical, (below). Of course, keep in mind that there are other factors to consider, too.

山東豐源化工已經在股份登記處設立了機構。事實上,他們擁有該公司可觀的股份。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看山東豐源化工過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

big
SZSE:002805 Earnings and Revenue Growth September 6th 2024
SZSE: 002805 收益和收入增長 2024 年 9 月 6 日

We note that hedge funds don't have a meaningful investment in Shandong Fengyuan Chemical. Looking at our data, we can see that the largest shareholder is Zhao Guanghui with 30% of shares outstanding. With 5.4% and 1.2% of the shares outstanding respectively, Jintong Anyi Investment Management Co., Ltd. and UBS Asset Management AG are the second and third largest shareholders.

我們注意到,對沖基金沒有對山東豐源化工進行有意義的投資。從我們的數據來看,我們可以看到最大股東是趙光輝,已發行股份的30%。金通安益投資管理有限公司和瑞銀資產管理股份公司分別擁有5.4%和1.2%的已發行股份,是第二和第三大股東。

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我們的研究表明,前25名股東共同控制的公司股份不到一半,這意味着該公司的股票分佈廣泛,沒有占主導地位的股東。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。據我們所知,沒有分析師對該公司進行報道,因此它可能處於雷達之下。

Insider Ownership Of Shandong Fengyuan Chemical

山東豐源化工的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

不同國家對內部人士的定義可能略有不同,但董事會成員始終算在內。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

Our information suggests that insiders maintain a significant holding in Shandong Fengyuan Chemical Co., Ltd.. Insiders own CN¥1.0b worth of shares in the CN¥3.3b company. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

我們的信息表明,內部人士持有山東豐源化工有限公司的大量股份。內部人士擁有這家33元人民幣公司價值10元人民幣的股份。很高興看到內部人士對這項業務進行如此投資。可能值得檢查一下這些內部人士最近是否在買入。

General Public Ownership

一般公有制

The general public, mostly comprising of individual investors, collectively holds 56% of Shandong Fengyuan Chemical shares. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

公衆主要由個人投資者組成,共持有山東豐源化工56%的股份。這種所有權規模賦予了公衆投資者一定的集體權力。他們可以而且可能確實會影響有關高管薪酬、股息政策和擬議業務收購的決策。

Private Equity Ownership

私募股權所有權

Private equity firms hold a 5.4% stake in Shandong Fengyuan Chemical. This suggests they can be influential in key policy decisions. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

私募股權公司持有山東豐源化工5.4%的股份。這表明他們可以在關鍵政策決策中發揮影響力。有些人可能會喜歡這樣,因爲私募股權有時是追究管理層責任的激進分子。但是其他時候,私募股權在公司上市後正在售罄。

Next Steps:

後續步驟:

It's always worth thinking about the different groups who own shares in a company. But to understand Shandong Fengyuan Chemical better, we need to consider many other factors. Be aware that Shandong Fengyuan Chemical is showing 3 warning signs in our investment analysis , and 2 of those are a bit concerning...

擁有公司股份的不同群體總是值得考慮的。但是,要更好地了解山東豐源化工,我們需要考慮許多其他因素。請注意,山東豐源化工在我們的投資分析中顯示出3個警告信號,其中2個有點令人擔憂...

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

當然,這可能不是最值得買入的股票。因此,您可能希望看到我們免費收集的具有良好財務狀況的有趣潛在客戶。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論